Cite

MLA Citation

    Thomas S. Uldrick et al.. “A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma.” Oncologist, vol. 22, 2017, pp. 505–e49. http://access.bl.uk/ark:/81055/vdc_100047413855.0x00001d
  
Back to record